CCR2 and inflammatory bowel disease: In contrast to inflammatory bowel disease (IBD) or infectious diseases of the gut, the inflammatory milieu instigated by DEP is not a consequence of increased CCR2+ pro-inflammatory macrophages, but decreased CCR2− anti-inflammatory/resident macrophages.